Salud financiera de hoja de balance de MedPeerInc

Salud financiera controles de criterios 4/6

MedPeerInc tiene un patrimonio de accionistas total de ¥8.8B y una deuda total de ¥3.7B, lo que sitúa su ratio deuda-patrimonio en 41.8%. Sus activos y pasivos totales son ¥15.0B y ¥6.2B respectivamente. El BAIT de MedPeerInc es de ¥1.1B, por lo que su ratio de cobertura de intereses es de 88.3. Tiene efectivo e inversiones a corto plazo que ascienden a ¥5.0B.

Información clave

41.8%

Ratio deuda-patrimonio

JP¥3.67b

Deuda

Ratio de cobertura de intereses	88.3x
Efectivo	JP¥4.98b
Patrimonio	JP¥8.78b
Total pasivo	JP¥6.20b
Activos totales	JP¥14.98b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (¥9.2B) de 6095 superan a sus pasivos a corto plazo (¥2.2B).

Pasivo a largo plazo: Los activos a corto plazo de 6095 (¥9.2B) superan a sus pasivos a largo plazo (¥4.0B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 6095 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 6095 ha crecido de 13.7% a 41.8% en los últimos 5 años.

Cobertura de la deuda: La deuda de 6095 no está bien cubierta por el flujo de caja operativo (16.4%).

Cobertura de intereses: Los pagos de intereses de la deuda de 6095 están bien cubiertos por el BAIT (88.3x cobertura).

Salud financiera de hoja de balance de MedPeerInc

Salud financiera controles de criterios 4/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

New minor risk - Market cap size

MedPeer,Inc. to Report Q2, 2024 Results on May 13, 2024

Consensus EPS estimates fall by 19%, revenue upgraded

Investor sentiment improves as stock rises 22%

First quarter 2024 earnings released: EPS: JP¥13.33 (vs JP¥12.40 in 1Q 2023)

New minor risk - Market cap size

Now 21% undervalued after recent price drop

MedPeer,Inc. to Report Q1, 2024 Results on Feb 13, 2024

New minor risk - Market cap size

Now 21% undervalued after recent price drop

Price target decreased by 9.1% to JP¥1,250

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 13%

Now 27% undervalued after recent price drop

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Now 21% undervalued after recent price drop

MedPeer,Inc. to Report Fiscal Year 2023 Results on Nov 13, 2023

Third quarter 2023 earnings released: EPS: JP¥1.28 (vs JP¥2.59 in 3Q 2022)

MedPeer,Inc. to Report Q3, 2023 Results on Aug 09, 2023

Now 22% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: JP¥5.02 (vs JP¥10.56 in 2Q 2022)

MedPeer,Inc. (TSE:6095) announces an Equity Buyback for 300,000 shares, representing 1.37% for ¥300 million.

Now 24% undervalued after recent price drop

First quarter 2023 earnings released: EPS: JP¥12.40 (vs JP¥17.15 in 1Q 2022)

MedPeer,Inc. (TSE:6095) acquired Business support application series of recruit Medical Career.

Price target decreased to JP¥2,300

MedPeer,Inc. to Report Q1, 2023 Results on Feb 13, 2023

Now 20% undervalued

Now 23% undervalued

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Consensus EPS estimates increase by 19%

MedPeer,Inc., Annual General Meeting, Dec 15, 2022

No independent directors

Price target decreased to JP¥2,600

MedPeer,Inc. (TSE:6095) completed the acquisition of Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others.

MedPeer,Inc. to Report Fiscal Year 2022 Results on Nov 14, 2022

Consensus EPS estimates fall by 30%

Consensus EPS estimates fall by 31%

Third quarter 2022 earnings released: EPS: JP¥2.59 (vs JP¥8.03 in 3Q 2021)

MedPeer,Inc. (TSE:6095) entered into an agreement to acquire Ep-Force Co.,Ltd. from EPS Holdings, Inc. and others for ¥5000 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Price target decreased to JP¥3,580

Investor sentiment deteriorated over the past week

MedPeer,Inc. to Report Q3, 2022 Results on Aug 09, 2022

Price target decreased to JP¥4,276

MedPeer,Inc. (TSE:6095) acquired Minkore recently.

Price target decreased to JP¥4,496

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

No independent directors

MedPeer,Inc. to Report Q2, 2022 Results on May 12, 2022

Now 23% undervalued

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS JP¥60.05 (vs JP¥34.99 in FY 2020)

Price target decreased to JP¥5,793

Third quarter 2021 earnings released: EPS JP¥8.03 (vs JP¥6.92 in 3Q 2020)

Price target decreased to JP¥6,293

Second quarter 2021 earnings released: EPS JP¥15.46 (vs JP¥9.17 in 2Q 2020)

MedPeer,Inc. to Report Q2, 2021 Results on May 13, 2021

New 90-day low: JP¥6,080

Analysts update estimates

First quarter 2021 earnings released: EPS JP¥20.34 (vs JP¥7.58 in 1Q 2020)

MedPeer,Inc. to Report Q1, 2021 Results on Feb 15, 2021

New 90-day high: JP¥7,270

Price target raised to JP¥6,043

New 90-day high: JP¥6,980

MedPeer,Inc., Annual General Meeting, Dec 17, 2020

MedPeer,Inc. to Report Fiscal Year 2020 Results on Nov 12, 2020

MedPeer,Inc. to Report Q3, 2020 Results on Aug 13, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio